Sonya Wakil
Psychiatry · Loveland, CONPI 1386832004
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.0% of the total across 110 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 20 manufacturers, the largest accounting for just 16.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $923 and has fallen 51.2% since, to $450 in 2025. Among psychiatry clinicians in CO with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 110 payments — averaging $18.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Corium, LLC$334
- Neurocrine Biosciences, Inc.$318
- AbbVie$309
- Takeda Pharmaceuticals U.S.A., Inc.$132
- Supernus Pharmaceuticals, Inc.$130
- Axsome Therapeutics, Inc.$115
- plus $734 from 14 others
What the payments were for
- Food & beverage$2,01097%
- Education$613%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Corium, LLC | 17 | $334 |
| Neurocrine Biosciences, Inc. | 10 | $318 |
| AbbVie(2 entities) | 19 | $309 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $132 |
| Supernus Pharmaceuticals, Inc. | 8 | $130 |
| Axsome Therapeutics, Inc. | 1 | $115 |
| Vertical Pharmaceuticals, LLC | 5 | $103 |
| Otsuka America Pharmaceutical, Inc. | 5 | $96 |
| Tris Pharma Inc | 7 | $94 |
| Sunovion Pharmaceuticals Inc. | 8 | $90 |
| Shire North American Group Inc | 4 | $70 |
| Johnson & Johnson | 4 | $66 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $40 |
| Lundbeck LLC | 2 | $36 |
| Neos Therapeutics, LP | 2 | $35 |
| Ironshore Pharmaceuticals Inc. | 1 | $29 |
| OWP Pharmaceuticals, Inc. | 1 | $22 |
| Alkermes, Inc. | 1 | $19 |
| Eisai Inc. | 1 | $18 |
| Collegium Pharmaceutical, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,072 in reported general payments places this provider in the 90th percentile of 559 psychiatry providers in Colorado.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Quetiapine Fumarate | 12 | $279 |
| Sertraline Hcl | 13 | $147 |
| Clonazepam | 19 | $34 |
Paid to pharmacies, not to this prescriber.
Other psychiatry in Loveland
- John HardyPueblo$828K
- Larry SandersLittleton$760K
- Jeffrey RichmondDenver$424K
- Jennifer FrenchGlendale$115K
- Charles ParkLone Tree$89K
- Cynthia EppersonAurora$64K
- Brian WiseCentennial$44K
- Robert CowanCentennial$29K
- Brenda CzabanDenver$25K
- John DequardoPueblo$17K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.